ctrl K

Watchlist Price Alert

Century Therapeutics Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

0.58

-0.00 (-0.51%)

At close: Jun 17, 2025, 10:54 AM

Century Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	6.59M	2.23M	5.2M	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	10.07M	4.58M	1.75M	249K
Gross Profit	6.59M	2.23M	-4.87M	-4.58M	-1.75M	-249K
Operating Income	-138.14M	-146.55M	-133.83M	-94.88M	-53.9M	-245.98M
Interest Income	13.01M	12.68M	2.99M	898K	704K	1.21M
Pretax Income	-124.78M	-134.79M	-130.84M	-95.78M	-53.58M	-244.77M
Net Income	-126.57M	-136.67M	-130.93M	-95.82M	-54.66M	-245.98M
Selling & General & Admin	33.16M	34.71M	31.86M	19.23M	9.49M	5.77M
Research & Development	107.24M	92.71M	107.17M	75.65M	39.68M	14.27M
Other Expenses	4.33M	21.36M	4.42M	377K	704K	1.21M
Operating Expenses	144.73M	148.78M	139.03M	94.88M	49.18M	20.03M
Interest Expense	n/a	540K	1.1M	1.27M	381K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	144.73M	148.78M	139.03M	94.88M	49.18M	20.03M
Income Tax Expense	1.79M	1.88M	91K	43K	1.08M	1.21M
Shares Outstanding (Basic)	78.65M	59.31M	57.76M	55.01M	54.82M	54.82M
Shares Outstanding (Diluted)	78.65M	59.31M	57.76M	55.01M	54.82M	54.82M
EPS (Basic)	-1.61	-2.3	-2.27	-1.74	-1	-4.49
EPS (Diluted)	-1.61	-2.3	-2.27	-1.74	-1	-4.49
EBITDA	-111.47M	-121.21M	-119.34M	-89.92M	-51.44M	-19.78M
EBIT	-124.78M	-134.25M	-129.64M	-94.51M	-53.19M	-244.77M
Depreciation & Amortization	13.3M	13.04M	10.07M	4.58M	1.75M	249K